Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic cefazolin for prevention of wound infection after laparoscopic cholecystectomy
IRCT20171126037629N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Nov 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cefazolin in gallbladder disease (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Visual analog scale pain score and Wound infection rate. Started Nov 2017; status: completed.
02
Drugs
cefazolin
03
Conditions
gallbladder disease
Beyond the preview
Go deeper on IRCT20171126037629N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171126037629N1.